INS and type 2 diabetes mellitus: Presently, a multicenter RCT is being conducted to assess the effects of adding metformin to insulin therapy for pregnant women diagnosed with type 2 diabetes (Wu et al., 2020; Newman and Dunne, 2022; Morin-Papunen et al., 2012; Vause et al., 2010).